Next Quarterly Earnings
Monday, August 10, 2026
CW 33
Pre-Market
In 36 days
TG Therapeutics
TG Therapeutics is a US-based biopharmaceutical company focused on the development and commercialization of novel therapies for patients with B-cell mediated diseases. This includes autoimmune conditions such as multiple sclerosis, as well as various oncology cancers. The company strives to provide innovative treatment options.
All Dates
Earnings history data not available
Company Information
Name
TG Therapeutics
Country
🇺🇸
More Financial Information